Zydus Recalls Paroxetine Tablets Due to Foreign Risperidone Contamination
Zydus Pharmaceuticals is recalling 44,800 bottles of 30mg Paroxetine tablets because foreign Risperidone tablets were found in the packaging.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves the presence of a foreign drug (risperidone) in a paroxetine bottle, which poses a significant risk of serious injury or adverse health consequences due to unintended medication intake.
Plain-English summary
Zydus Pharmaceuticals USA Inc. is recalling 44,800 bottles of Paroxetine tablets USP, 30mg, 30-count. The recall was initiated because foreign Risperidone tablets were found in bottles of Paroxetine tablets. The affected product is Lot # Z701133 with an expiration date of 03/19, distributed nationwide within the United States.
The product is a prescription-only medication manufactured by Cadila Healthcare Ltd in Ahmedabad, India, and distributed by Zydus Pharmaceuticals USA, Inc. in Pennington, NJ. The specific NDC for the recalled item is 68382-099-06.
Consumers who have this specific lot of Paroxetine should stop using it and contact their healthcare provider or pharmacist for guidance. The FDA has classified this recall as Class II, indicating a reasonable probability that temporary or medically reversible adverse health consequences could occur.
The recalled product
- Product
- PAROXETINE (PAROXETINE)
- Brand
- PAROXETINE
- Manufacturer
- Zydus Pharmaceuticals USA Inc
- Category
- Drug — Prescription Medication
- Affected units
- 44,800
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: Z701133
- Exp 03/19
UPCs (3)
- 0368382098108
- 0368382099105
- 368382099068
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PAROXETINE
- HighParoxetine Tablets Recalled Due to Out-of-Specification Impurity Levels
FDA (Drugs) · 2023-12-06
- HighParoxetine Hydrochloride 30 mg Tablets Recalled for Impurity Specification Failure
FDA (Drugs) · 2023-12-06
- ModerateParoxetine Tablets Recalled Due to Manufacturing Specification Failure
FDA (Drugs) · 2023-12-06
- ModerateParoxetine 20 mg Tablets Recalled for Out-of-Specification Impurity
FDA (Drugs) · 2023-12-06
- HighParoxetine Hydrochloride Tablets Recalled for Out-of-Specification Impurity
FDA (Drugs) · 2023-12-06
Same manufacturer · Zydus Pharmaceuticals USA Inc
See all →- SevereFDA Recalls Mirabegron Tablets Over Nitrosamine Impurity
FDA (Drugs) · 2026-08-12
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- HighIcosapent ethyl capsules recalled after active ingredient oxidized inside capsule
FDA (Drugs) · 2026-03-18
- HighIcosapent ethyl capsules recalled as subpotent after capsule contents leaked
FDA (Drugs) · 2026-01-28
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02